Review
Published on 10 Nov 2022
ALT-803 in the treatment of non-muscle-invasive bladder cancer: Preclinical and clinical evidence and translational potential
in Cancer Immunity and Immunotherapy
- 13,103 views
- 27 citations
Review
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Review
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Review
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Case Report
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Review
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Review
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Review
Published on 10 Nov 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 09 Nov 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 09 Nov 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 09 Nov 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 09 Nov 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 09 Nov 2022
in Cancer Immunity and Immunotherapy